XDH and hyperuricemia: The Beneficial Effect by Xanthine Oxidase Inhibitor on Endothelial Function Beyond Uric Acid (BEYOND-UA) study was the first randomized, controlled trial comparing the effects of the XOR inhibitors, topiroxostat and febuxostat, on arterial stiffness parameters in Japanese hypertensive patients with hyperuricemia [16].